covicis Publications
Our Scientific Publications
Genomic characterization of Dengue virus circulation in Ethiopia
Abera et al. Emerging Infectious Diseases. March 2025
SARS-CoV-2 infectivity can be modulated through bacterial grooming of the glycocalyx
Martino et al. mBio. February 2025
SARS-CoV-2 Infections in a Triad of Primary School Learners (Grades 1-7), Their Parents, and Teachers in KwaZulu-Natal, South Africa: Protocol for a Cross-Sectional and Nested Case-Cohort Study
Dassaye et al. Journal of Medical Internet Research. 2024 Dec 19:13:e52713
Dengue virus importation risks in Africa: a modelling study
Poongavanan et al. Lancet Planet Health. December 2024
A global collaborative comparison of SARS-CoV-2 antigenicity across 15 laboratories
Brangel et al. J Med Virol. December 2024
Patterns of C1-Inhibitor Plasma Levels and Kinin-Kallikrein System Activation in Relation to COVID-19 Severity
Berra et al. Life (Basel). November 2024
Immune escape and replicative capacity of Omicron lineages BA.1, BA.2, BA.5.1, BQ.1, XBB.1.5, EG.5.1 and JN.1.1
Bekliz et al. Biorxiv. October 2024
Relationship between thyroid function and lipid atherogenic profile in pediatric patients with multisystem inflammatory syndrome associated with COVID-19
Calcaterra et al. Frontiers in Pediatrics. October 2024
GENOMIC EPIDEMIOLOGY OF THE MAIN SARS-CoV-2 VARIANTS CIRCULATING IN ITALY DURING THE OMICRON ERA
Bergna et al. Authorea. August 2024
SARS-CoV-2 Genomic Epidemiology Dashboards: A Review of Functionality and Technological Frameworks for the Public Health Response
Sitharam et al. Genes (Basel). 2024 Jul 3;15(7):876.
Impacts of climate change-related human migration on infectious diseases
Tsui et al. Nature Climate Change. Volume 14, pages793–802 (2024)
Long-COVID symptom monitoring: Insights from a two-year telemedicine study
Foppiani et al. PLOS ONE. July 2024
SARS-CoV-2 humoral immunity in people living with HIV-1
Motsoeneng et al. Trends in Immunology. 2024 Jul;45(7):511-522.
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients
Dalu et al. International Journal of Cancer. 2024 Apr 15;154(8):1371-1376.
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants
Riou et al. PLOS Glob Public Health. 2024 Apr 11;4(4):e0002703.
SARS-CoV-2 Viral Replication Persists in the Human Lung for Several Weeks after Symptom Onset
Tomasicchio et al. American Journal of Respiratory and Critical Care Medicine. 2024 Apr 1;209(7):840-851.
Unsaturated fatty acids, omega-3 index and hospitalization in MISC.
Di Profio et al. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA). March 2024
Long-term effects of SARS-CoV-2 infection in hospitalized children: findings from an Italian single-center study
Calcaterra et al. Italian Journal of Pediatrics. 2024 Feb 14;50(1):27.
Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell response
Butters et al. Clinical Immunology. 2024 Feb:259:109877
Distinct T cell functional profiles in SARS-CoV-2 seropositive and seronegative children associated with endemic human coronavirus cross-reactivity
Benede et al. iScience. Volume 27, Issue 1, 19 January 2024, 108728
Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021.
Bergna et al. Journal of Medical Virology. 2023 Nov;95(11):e29193.
Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study
Raineri et al. Nature Communications. 2023 Nov 27;14(1):7764.
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination
Varasi et al. Journal of Infection. 2023 Sep;87(3):270-272.
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination
Motsoeneng et al. Front Immunol. 2023 Aug 3:14:1231276.
Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients
Fallet et al. Journal of Infection. 2023 Aug;87(2):111-119.
Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1
Tsui et al. Science. 2023 Jul 21;381(6655):336-343
Dispersal patterns and influence of air travel during the global expansion of SARS-CoV-2 variants of concern
Tegally et al. Cell. 2023 Jul 20;186(15):3277-3290.e16
Post COVID-19 condition, work ability and occupational changes in a population-based cohort
Kerksieck et al. The Lancet Regional Health - Lancet Reg Health Eur. 2023 Jun 23:31:100671
Clinical efficacy of the first two doses of anti-SARS-CoV-2 mRNA vaccines in solid cancer patients
Cona et al. Cancer Medicine. 2023 Jun;12(12):12967-12974
Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study
Ballouz et al. BMJ. 2023 May 31:381:e074425
Longitudinal Anthropometry and Body Composition in Children With SARS-CoV-2-Associated Multisystem Inflammatory Syndrome
Di Profio et al. Journal of Pediatric Gastroenterology and Nutrition. 2023 Apr 1;76(4):505-511
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection
La Verde et al. International Journal of Cancer. 2023 Feb; 152(4)
Six-month multidisciplinary follow-up in multisystem inflammatory syndrome in children: An Italian single-center experience
Zuccotti et al. Frontiers in Pediatrics. 2023 Jan 26;10:1080654
CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses
Noto et al. Viruses. 2022 Nov 28;14(12):2665
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy
Lai et al. Viruses. 2022 Nov 12;14(11):2508
Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients
Wiedemann et al. Frontiers in Medicine (Lausanne). 2022 Aug 22;9:978764
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients
Obeid et al. JAMA Oncology. 2022 May 1;8(5):e220446
Funded (partially) by the European Union Horizon Europe program, under project “EU-Africa Concerted Action on SAR-CoV-2 Virus Variant and Immunological Surveillance” (Acronym: CoVICIS, grant nr: 101046041). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
CoVICIS is funded by the European Union’s Horizon Europe Research and Innovation Programme under grant nr 101046041